LabConnect Joins the United Nations Global Compact, Strengthening Commitment to Sustainability and Ethical Business Practices

Johnson City, TN, February 11, 2025 – LabConnect, a global leader in central laboratory services and functional service provider solutions for clinical trials, is proud to announce its participation as a signatory to the United Nations Global Compact. By joining this prestigious initiative, LabConnect commits to aligning its strategies and operations with the Ten Principles of the UN Global Compact, covering human rights, labor, environment, and anti-corruption.

This commitment reinforces LabConnect’s mission to create healthier communities by supporting our clients in successfully developing new medicines for patients around the world, while ensuring its operations reflect the highest standards of sustainability, integrity, and corporate responsibility. As part of this pledge, LabConnect will actively work to advance the UN Sustainable Development Goals (SDGs) and report annually on its progress in integrating the principles into its business practices.

“Joining the UN Global Compact is a natural extension of LabConnect’s deep commitment to sustainability and ESG leadership,” said Wes Wheeler, CEO of LabConnect. “This milestone demonstrates our determination to uphold ethical business practices, foster a healthier planet, and contribute meaningfully to global sustainability goals. We are proud to join this global community of changemakers.”

Through its participation in the UN Global Compact, LabConnect will collaborate with like-minded organizations worldwide, leveraging shared resources and best practices to continue delivering innovative, impactful solutions in clinical trials while driving positive change for people and the planet.

For more information about LabConnect’s sustainability initiatives, visit https://www.labconnect.com/esg/.

About LabConnect

LabConnect is the leading provider of Central Laboratory Services, FSP and Scientific Consulting, and Data Integration and Transformation Services for analytically and logistically complex studies such as immuno-oncology, cell and gene therapies, and rare & orphan diseases. LabConnect’s unique combination of state-of-the-art technology, world-class laboratories, easy access to major and emerging markets, and extensive specialized testing expertise means that drug development companies can rely on one provider for all their central laboratory service needs. Learn more at www.labconnect.com and follow on LinkedIn.